194 related articles for article (PubMed ID: 35328403)
21. Downregulation of β1 -adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort.
Jakobs D; Hage-Hülsmann A; Prenner L; Kolb C; Weiser D; Häberlein H
J Pharm Pharmacol; 2013 Jun; 65(6):907-15. PubMed ID: 23647684
[TBL] [Abstract][Full Text] [Related]
22. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
[TBL] [Abstract][Full Text] [Related]
23. Development of new and validated HPTLC methods for the qualitative and quantitative analysis of hyperforin, hypericin and hyperoside contents in Hypericum species.
Saçıcı E; Yesilada E
Phytochem Anal; 2022 Apr; 33(3):355-364. PubMed ID: 34734668
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of hyperforin analogues for inhibition of 5-lipoxygenase.
Feisst C; Albert D; Verotta L; Werz O
Med Chem; 2005 May; 1(3):287-91. PubMed ID: 16787324
[TBL] [Abstract][Full Text] [Related]
25. St. John's wort extract and hyperforin inhibit multiple phosphorylation steps of cytokine signaling and prevent inflammatory and apoptotic gene induction in pancreatic β cells.
Novelli M; Menegazzi M; Beffy P; Porozov S; Gregorelli A; Giacopelli D; De Tata V; Masiello P
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):92-104. PubMed ID: 27780755
[TBL] [Abstract][Full Text] [Related]
26. St. John's Wort reduces beta-amyloid accumulation in a double transgenic Alzheimer's disease mouse model-role of P-glycoprotein.
Brenn A; Grube M; Jedlitschky G; Fischer A; Strohmeier B; Eiden M; Keller M; Groschup MH; Vogelgesang S
Brain Pathol; 2014 Jan; 24(1):18-24. PubMed ID: 23701205
[TBL] [Abstract][Full Text] [Related]
27. Enrichment of hyperforin from St. John's wort (Hypericum perforatum) by pilot-scale supercritical carbon dioxide extraction.
Römpp H; Seger C; Kaiser CS; Haslinger E; Schmidt PC
Eur J Pharm Sci; 2004 Mar; 21(4):443-51. PubMed ID: 14998574
[TBL] [Abstract][Full Text] [Related]
28. A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer.
Reabroi S; Chairoungdua A; Saeeng R; Kasemsuk T; Saengsawang W; Zhu W; Piyachaturawat P
Biomed Pharmacother; 2018 May; 101():414-421. PubMed ID: 29501763
[TBL] [Abstract][Full Text] [Related]
29. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
Bouron A; Lorrain E
Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
[TBL] [Abstract][Full Text] [Related]
30. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
Muruganandam AV; Bhattacharya SK; Ghosal S
Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
[TBL] [Abstract][Full Text] [Related]
31. The production of hypericins and hyperforin by in vitro cultures of St. John's wort (Hypericum perforatum).
Kirakosyan A; Sirvent TM; Gibson DM; Kaufman PB
Biotechnol Appl Biochem; 2004 Feb; 39(Pt 1):71-81. PubMed ID: 14521510
[TBL] [Abstract][Full Text] [Related]
32. Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage.
Ang CY; Hu L; Heinze TM; Cui Y; Freeman JP; Kozak K; Luo W; Liu FF; Mattia A; DiNovi M
J Agric Food Chem; 2004 Oct; 52(20):6156-64. PubMed ID: 15453681
[TBL] [Abstract][Full Text] [Related]
33. Hyperforin analogues from St. John's wort (Hypericum perforatum).
Verotta L; Appendino G; Jakupovic J; Bombardelli E
J Nat Prod; 2000 Mar; 63(3):412-5. PubMed ID: 10757735
[TBL] [Abstract][Full Text] [Related]
34. Correlation of hyperforin content of Hypericum perforatum (St John's Wort) extracts with their effects on alcohol drinking in C57BL/6J mice: a preliminary study.
Wright CW; Gott M; Grayson B; Hanna M; Smith AG; Sunter A; Neill JC
J Psychopharmacol; 2003 Dec; 17(4):403-8. PubMed ID: 14870952
[TBL] [Abstract][Full Text] [Related]
35. Downstream processing of hyperforin from Hypericum perforatum root cultures.
Haas P; Gaid M; Zarinwall A; Beerhues L; Scholl S
Eur J Pharm Biopharm; 2018 May; 126():104-107. PubMed ID: 28669795
[TBL] [Abstract][Full Text] [Related]
36. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures.
Komoroski BJ; Parise RA; Egorin MJ; Strom SC; Venkataramanan R
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6972-9. PubMed ID: 16203790
[TBL] [Abstract][Full Text] [Related]
37. Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels.
Leuner K; Kazanski V; Müller M; Essin K; Henke B; Gollasch M; Harteneck C; Müller WE
FASEB J; 2007 Dec; 21(14):4101-11. PubMed ID: 17666455
[TBL] [Abstract][Full Text] [Related]
38. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
Hostanska K; Reichling J; Bommer S; Weber M; Saller R
Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
[TBL] [Abstract][Full Text] [Related]
39. Hypericum perforatum extract and hyperforin inhibit the growth of neurotropic parasite Toxoplasma gondii and infection-induced inflammatory responses of glial cells in vitro.
Shinjyo N; Nakayama H; Li L; Ishimaru K; Hikosaka K; Suzuki N; Yoshida H; Norose K
J Ethnopharmacol; 2021 Mar; 267():113525. PubMed ID: 33129946
[TBL] [Abstract][Full Text] [Related]
40. Biotechnological production of hyperforin for pharmaceutical formulation.
Gaid M; Biedermann E; Füller J; Haas P; Behrends S; Krull R; Scholl S; Wittstock U; Müller-Goymann C; Beerhues L
Eur J Pharm Biopharm; 2018 May; 126():10-26. PubMed ID: 28377273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
